December 27, 2024
Optinose Announces 1-for-15 Reverse Stock Split
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) — Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by…
Pharmaceuticals, Biotechnology and Life Sciences
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) — Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by…
WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the…
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada,…
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), announced that AutoMax Motors…
– Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the…
PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health…
Vancouver, Canada, Dec. 24, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a…
• 630 Patients Enrolled To Date; Enrollment Completion Now Expected in Q1 2025 with Top-line Results Anticipated in Q2 2025;…
BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”) is pleased to…
TEL AVIV, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that…